In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Preservation of Antibiotics for 
Medical Treatment Act of 2011''.

SEC. 2. FINDINGS.

    The Congress finds the following:
            (1) In January 2001, a Federal interagency task force--
                    (A) released an action plan to address the 
                continuing decline in effectiveness of antibiotics 
                against common bacterial infections, referred to as 
                antibiotic resistance;
                    (B) determined that antibiotic resistance is a 
                growing menace to all people and poses a serious threat 
                to public health; and
                    (C) cautioned that if current trends continue, 
                treatments for common infections will become 
                increasingly limited and expensive, and, in some cases, 
                nonexistent.
            (2) Antibiotic resistance, resulting in a reduced number of 
        effective antibiotics, may significantly impair the ability of 
        the United States to respond to terrorist attacks involving 
        bacterial infections or a large influx of hospitalized 
        patients.
            (3)(A) Any overuse or misuse of antibiotics contributes to 
        the spread of antibiotic resistance, whether in human medicine 
        or in agriculture.
            (B) Recognizing the public health threat caused by 
        antibiotic resistance, Congress took several steps to curb 
        antibiotic overuse in human medicine through amendments to the 
        Public Health Service Act (42 U.S.C. 201 et seq.) made by 
        section 102 of the Public Health Threats and Emergencies Act 
        (Public Law 106-505, title I; 114 Stat. 2315), but has not yet 
        addressed antibiotic overuse in agriculture.
            (4) In a March 2003 report, the National Academy of 
        Sciences stated that--
                    (A) a decrease in antimicrobial use in human 
                medicine alone will have little effect on the current 
                situation; and
                    (B) substantial efforts must be made to decrease 
                inappropriate overuse in animals and agriculture.
            (5) In 2010, the FDA determined that--
                    (A) 13.1 million kilograms of antibacterial drugs 
                were sold for use on food animals in the United States 
                in 2009;
                    (B) 3.3 million kilograms of antibacterial drugs 
                were used for human health in 2009; and
                    (C) therefore, 80 percent of antibacterial drugs 
                disseminated in the United States in 2009 were sold for 
                use on food animals, rather than being used for human 
                health.
            (6)(A) Large-scale, voluntary surveys by the Department of 
        Agriculture's Animal and Plant Health Inspection Service in 
        1999, 2001, and 2006 revealed that--
                    (i) 84 percent of grower-finisher swine farms, 83 
                percent of cattle feedlots, and 84 percent of sheep 
                farms administer antimicrobials in the feed or water 
                for health or growth promotion reasons; and
                    (ii) many of the antimicrobials identified are 
                identical or closely related to drugs used in human 
                medicine, including tetracyclines, macrolides, 
                Bacitracin, penicillins, and sulfonamides; and
            (B) these drugs are used in people to treat serious 
        diseases such as pneumonia, scarlet fever, rheumatic fever, 
        venereal disease, skin infections, and even pandemics like 
        malaria and plague, as well as bioterrorism agents like 
        smallpox and anthrax.
            (7) Many scientific studies confirm that the nontherapeutic 
        use of antibiotics in agricultural animals contributes to the 
        development of antibiotic-resistant bacterial infections in 
        people.
            (8) The periodical entitled ``Clinical Infectious 
        Diseases'' published a report in June 2002, that--
                    (A) was based on a 2-year review by experts in 
                human and veterinary medicine, public health, 
                microbiology, biostatistics, and risk analysis, of more 
                than 500 scientific studies on the human health impacts 
                of antimicrobial use in agriculture; and
                    (B) recommended that antimicrobial agents should no 
                longer be used in agriculture in the absence of 
                disease, but should be limited to therapy for diseased 
                individual animals and prophylaxis when disease is 
                documented in a herd or flock.
            (9) The United States Geological Survey reported in March 
        2002 that--
                    (A) antibiotics were present in 48 percent of the 
                streams tested nationwide; and
                    (B) almost half of the tested streams were 
                downstream from agricultural operations.
            (10) An April 1999 study by the General Accounting Office 
        concluded that resistant strains of 3 microorganisms that cause 
        food-borne illness or disease in humans (Salmonella, 
        Campylobacter, and E. coli) are linked to the use of 
        antibiotics in animals.
            (11) Epidemiological research has shown that resistant 
        Salmonella and Campylobacter infections are associated with 
        increased numbers of ill patients and bloodstream infections, 
        and increased death.
            (12) In 2010, the peer-reviewed journal Molecular Cell 
        published a study demonstrating that low-dosage use of 
        antibiotics causes a dramatic increase in genetic mutation, 
        raising new concerns about the agricultural practice of using 
        low-dosage antibiotics in order to stimulate growth promotion 
        and routinely prevent disease in unhealthy conditions.
            (13)(A) In January 2003, Consumer Reports published test 
        results on poultry products bought in grocery stores nationwide 
        showing disturbingly high levels of Campylobacter and 
        Salmonella bacteria that were resistant to the antibiotics used 
        to treat food-borne illnesses.
            (B) The Food and Drug Administration's National 
        Antimicrobial Resistance Monitoring System routinely finds that 
        retail meat products are contaminated with bacteria (including 
        the foodborne pathogens Campylobacter and Salmonella) that are 
        resistant to antibiotics important in human medicine.
            (C) In December 2007, the USDA issued a fact sheet on the 
        recently recognized link between antimicrobial drug use in 
        animals and Methicillin Resistant Staphylococcus Aureas (MRSA) 
        infections in humans.
            (14) In October 2001, the New England Journal of Medicine 
        published an editorial urging a ban on nontherapeutic use of 
        medically important antibiotics in animals.
            (15)(A) In 1998, the National Academy of Sciences noted 
        that antibiotic-resistant bacteria generate a minimum of 
        $4,000,000,000 to $5,000,000,000 in costs to United States 
        society and individuals yearly.
            (B) In 2009, Cook County Hospital and the Alliance for 
        Prudent Use of Antibiotics estimated that the total health care 
        cost of antibiotic resistant infections in the United States 
        was between $16,600,000,000 and $26,000,000,000 annually.
            (16) The American Medical Association, the American Public 
        Health Association, the National Association of County and City 
        Health Officials, and the National Campaign for Sustainable 
        Agriculture are among the more than 300 organizations 
        representing health, consumer, agricultural, environmental, 
        humane, and other interests that have supported enactment of 
        legislation to phase out nontherapeutic use in farm animals of 
        medically important antibiotics.
            (17) In 2010, the Danish Veterinary and Food Administration 
        testified that the Danish ban of the non-therapeutic use of 
        antibiotics in food animal production resulted in a marked 
        reduction in antimicrobial resistance in multiple bacterial 
        species, including Campylobacter and Enterococci.
            (18) In 2009, the Congressional Research Service concluded 
        that restrictions overseas on the use of antimicrobial drugs in 
        the production of livestock could impact U.S. export markets 
        for livestock and poultry.
            (19) The Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
        301 et seq.)--
                    (A) requires that all drugs be shown to be safe 
                before the drugs are approved; and
                    (B) places the burden on manufacturers to account 
                for health consequences and prove safety.
            (20)(A) The Food and Drug Administration recently modified 
        the drug approval process for antibiotics to recognize the 
        development of resistant bacteria as an important aspect of 
        safety, but most antibiotics currently used in animal 
        production systems for nontherapeutic purposes were approved 
        before the Food and Drug Administration began considering 
        resistance during the drug-approval process.
            (B) The Food and Drug Administration has not established a 
        schedule for reviewing those existing approvals.
            (21) Certain non-routine uses of antibiotics in animal 
        agriculture are legitimate to prevent animal disease.
            (22) An April 2004 study by the General Accounting Office--
                    (A) concluded that Federal agencies do not collect 
                the critical data on antibiotic use in animals that 
                they need to support research on human health risks; 
                and
                    (B) recommends that the Department of Agriculture 
                and the Department of Health and Human Services develop 
                and implement a plan to collect data on antibiotic use 
                in animals.

SEC. 3. PURPOSE.

    The purpose of this Act is to preserve the effectiveness of 
medically important antibiotics used in the treatment of human and 
animal diseases by reviewing the safety of certain antibiotics for 
nontherapeutic purposes in food-producing animals.

SEC. 4. PROOF OF SAFETY OF CRITICAL ANTIMICROBIAL ANIMAL DRUGS.

    (a) Definitions.--Section 201 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 321) is amended by adding at the end the 
following:
    ``(ss) Critical Antimicrobial Animal Drug.--The term `critical 
antimicrobial animal drug' means a drug that--
            ``(1) is intended for use in food-producing animals; and
            ``(2) is composed wholly or partly of--
                    ``(A) any kind of penicillin, tetracycline, 
                macrolide, lincosamide, streptogramin, aminoglycoside, 
                or sulfonamide; or
                    ``(B) any other drug or derivative of a drug that 
                is used in humans or intended for use in humans to 
                treat or prevent disease or infection caused by 
                microorganisms.
    ``(tt) Nontherapeutic Use.--The term `nontherapeutic use', with 
respect to a critical antimicrobial animal drug, means any use of the 
drug as a feed or water additive for an animal in the absence of any 
clinical sign of disease in the animal for growth promotion, feed 
efficiency, weight gain, routine disease prevention, or other routine 
purpose.''.
    (b) Applications Pending or Submitted After Enactment.--Section 
512(d)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
360b(d)(1)) is amended--
            (1) in the first sentence--
                    (A) in subparagraph (H), by striking ``or'' at the 
                end;
                    (B) in subparagraph (I), by inserting ``or'' at the 
                end; and
                    (C) by inserting after subparagraph (I) the 
                following:
                    ``(J) with respect to a critical antimicrobial 
                animal drug or a drug of the same chemical class as a 
                critical antimicrobial animal drug, the applicant has 
                failed to demonstrate that there is a reasonable 
                certainty of no harm to human health due to the 
                development of antimicrobial resistance that is 
                attributable, in whole or in part, to the 
                nontherapeutic use of the drug; or''; and
            (2) in the second sentence, by striking ``(A) through (I)'' 
        and inserting ``(A) through (J)''.
    (c) Phased Elimination of Nontherapeutic Use in Animals of Critical 
Antimicrobial Animal Drugs Important for Human Health.--Section 512 of 
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b) is amended by 
adding at the end the following:
    ``(q) Phased Elimination of Nontherapeutic Use in Animals of 
Critical Antimicrobial Animal Drugs Important for Human Health.--
            ``(1) Applicability.--This subsection applies to the 
        nontherapeutic use in a food-producing animal of a drug--
                    ``(A)(i) that is a critical antimicrobial animal 
                drug; or
                    ``(ii) that is of the same chemical class as a 
                critical antimicrobial animal drug; and
                    ``(B)(i) for which there is in effect an approval 
                of an application or an exemption under subsection (b), 
                (i), or (j) of section 505; or
                    ``(ii) that is otherwise marketed for use.
            ``(2) Withdrawal.--The Secretary shall withdraw the 
        approval of a nontherapeutic use in food-producing animals 
        described in paragraph (1) on the date that is 2 years after 
        the date of enactment of this subsection unless--
                    ``(A) before the date that is 2 years after the 
                date of the enactment of this subsection, the Secretary 
                makes a final written determination that the holder of 
                the approved application has demonstrated that there is 
                a reasonable certainty of no harm to human health due 
                to the development of antimicrobial resistance that is 
                attributable in whole or in part to the nontherapeutic 
                use of the drug; or
                    ``(B) before the date specified in subparagraph 
                (A), the Secretary makes a final written determination 
                under this subsection, with respect to a risk analysis 
                of the drug conducted by the Secretary and other 
                relevant information, that there is a reasonable 
                certainty of no harm to human health due to the 
                development of antimicrobial resistance that is 
                attributable in whole or in part to the nontherapeutic 
                use of the drug.
            ``(3) Exemptions.--Except as provided in paragraph (5), if 
        the Secretary grants an exemption under section 505(i) for a 
        drug that is a critical antimicrobial animal drug, the 
        Secretary shall rescind each approval of a nontherapeutic use 
        in a food-producing animal of the critical antimicrobial animal 
        drug, or of a drug in the same chemical class as the critical 
        antimicrobial animal drug, as of the date that is 2 years after 
        the date on which the Secretary grants the exemption.
            ``(4) Approvals.--Except as provided in paragraph (5), if 
        an application for a drug that is a critical antimicrobial 
        animal drug is submitted to the Secretary under section 505(b), 
        the Secretary shall rescind each approval of a nontherapeutic 
        use in a food-producing animal of the critical antimicrobial 
        animal drug, or of a drug in the same chemical class as the 
        critical antimicrobial animal drug, as of the date that is 2 
        years after the date on which the application is submitted to 
        the Secretary.
            ``(5) Exception.--Paragraph (3) or (4), as the case may be, 
        shall not apply if--
                    ``(A) before the date on which approval would be 
                rescinded under that paragraph, the Secretary makes a 
                final written determination that the holder of the 
                application for the approved nontherapeutic use has 
                demonstrated that there is a reasonable certainty of no 
                harm to human health due to the development of 
                antimicrobial resistance that is attributable in whole 
                or in part to the nontherapeutic use in the food-
                producing animal of the critical antimicrobial animal 
                drug; or
                    ``(B) before the date specified in subparagraph 
                (A), the Secretary makes a final written determination 
                under this subsection, with respect to a risk analysis 
                of the critical antimicrobial animal drug conducted by 
                the Secretary and any other relevant information, that 
                there is a reasonable certainty of no harm to human 
                health due to the development of antimicrobial 
                resistance that is attributable in whole or in part to 
                the nontherapeutic use of the drug.''.

SEC. 5. COMMITTEE HEARINGS ON IMPLEMENTATION.

    (a) In General.--The Committee on Energy and Commerce of the House 
of Representatives and the Committee on Energy of the Senate shall each 
hold a hearing on the implementation by the Commissioner of Food and 
Drugs of section 512(q) of the Federal Food, Drug, and Cosmetic Act, as 
added by section 4 of this Act.
    (b) Exercise of Rulemaking Authority.--Subsection (a) is enacted--
            (1) as an exercise of the rulemaking power of the House of 
        Representatives and Senate, and, as such, they shall be 
        considered as part of the rules of the House or Senate (as the 
        case may be), and such rules shall supersede any other rule of 
        the House or Senate only to the extent that rule is 
        inconsistent therewith; and
            (2) with full recognition of the constitutional right of 
        either House to change such rules (so far as relating to the 
        procedure in such House) at any time, in the same manner, and 
        to the same extent as in the case of any other rule of the 
        House or Senate.
[EX A]: Preservation of Antibiotics for Medical Treatment Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services (HHS) to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms.

Requires the Secretary to withdraw approval of a nontherapeutic use of such drugs in food-producing animals two years after the date of enactment of this Act unless certain safety requirements are met. Directs specified congressional committees to hold hearings on the implementation of such a withdrawal of approval.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Security Contractor Accountability 
Act of 2007''.

SEC. 2. LEGAL STATUS OF CONTRACT PERSONNEL.

    (a) Clarification of the Military Extraterritorial Jurisdiction 
Act.--
            (1) Inclusion of contractors.--Subsection (a) of section 
        3261 of title 18, United States Code, is amended--
                    (A) by striking ``or'' at the end of paragraph (1);
                    (B) by striking the comma at the end of paragraph 
                (2) and inserting ``; or''; and
                    (C) by inserting after paragraph (2) the following:
            ``(3) while employed under a contract (or subcontract at 
        any tier) awarded by any department or agency of the United 
        States, where the work under such contract is carried out in an 
        area, or in close proximity to an area (as designated by the 
        Department of Defense), where the Armed Forces is conducting a 
        contingency operation,''.
            (2) Definition.--Section 3267 of title 18, United States 
        Code, is amended by adding at the end the following:
            ``(5) The term `contingency operation' has the meaning 
        given such term in section 101(a)(13) of title 10.''.
    (b) Department of Justice Inspector General Report.--
            (1) Report required.--Not later than 180 days after the 
        date of the enactment of this Act, the Inspector General of the 
        Department of Justice shall submit to Congress a report in 
        accordance with this subsection.
            (2) Content of report.--The report under paragraph (1) 
        shall include--
                    (A) a description of the status of Department of 
                Justice investigations of alleged violations of section 
                3261 of title 18, United States Code, to have been 
                committed by contract personnel, which shall include--
                            (i) the number of complaints received by 
                        the Department of Justice;
                            (ii) the number of investigations into 
                        complaints opened by the Department of Justice;
                            (iii) the number of criminal cases opened 
                        by the Department of Justice; and
                            (iv) the number and result of criminal 
                        cases closed by the Department of Justice; and
                    (B) findings and recommendations about the number 
                of criminal cases prosecuted by the Department of 
                Justice involving violations of section 3261 of title 
                18, United States Code.
            (3) Format of report.--The report under paragraph (1) shall 
        be submitted in unclassified format, but may contain a 
        classified annex as appropriate.

SEC. 3. FEDERAL BUREAU OF INVESTIGATION INVESTIGATIVE UNIT FOR 
              CONTINGENCY OPERATIONS.

    (a) Establishment of Theater Investigative Unit.--The Director of 
the Federal Bureau of Investigation shall ensure that there are 
adequate personnel through the creation of Theater Investigative Units 
to investigate allegations of criminal violations of section 3261 of 
title 18, United States Code, by contract personnel.
    (b) Responsibilities of Theater Investigative Unit.--The Theater 
Investigative Unit established for a theater of operations shall--
            (1) investigate reports that raise reasonable suspicion of 
        criminal misconduct by contract personnel;
            (2) investigate reports of fatalities resulting from the 
        use of force by contract personnel; and
            (3) upon conclusion of an investigation of alleged criminal 
        misconduct, refer the case to the Attorney General of the 
        United States for further action, as appropriate in the 
        discretion of the Attorney General.
    (c) Responsibilities of Federal Bureau of Investigation.--
            (1) Resources.--The Director of the Federal Bureau of 
        Investigation shall ensure that each Theater Investigative Unit 
        has adequate resources and personnel to carry out its 
        responsibilities.
            (2) Notification.--The Director of the Federal Bureau of 
        Investigation shall notify Congress whenever a Theater 
        Investigative Unit is established or terminated in accordance 
        with this section.
    (d) Responsibilities of Other Federal Agencies.--An agency 
operating in an area, or in close proximity to an area (as designated 
by the Department of Defense), where the Armed Forces is conducting a 
contingency operation shall cooperate with and support the activities 
of the Theater Investigative Unit. Any investigation carried out by the 
Inspector General of an agency shall be coordinated with the activities 
of the Theater Investigative Unit as appropriate.

SEC. 4. DEFINITIONS.

    In this Act:
            (1) Covered contract.--The term ``covered contract'' means 
        an agreement--
                    (A) that is--
                            (i) a prime contract awarded by an agency;
                            (ii) a subcontract at any tier under any 
                        prime contract awarded by an agency; or
                            (iii) a task order issued under a task or 
                        delivery order contract entered into by an 
                        agency; and
                    (B) according to which the work under such 
                contract, subcontract, or task order is carried out in 
                a region outside the United States in which the Armed 
                Forces are conducting a contingency operation.
            (2) Agency.--The term ``agency'' has the meaning given the 
        term ``Executive agency'' in section 105 of title 5, United 
        States Code.
            (3) Contingency operation.--The term ``contingency 
        operation'' has the meaning given the term section 101(13) of 
        title 10, United States Code.
            (4) Contractor.--The term ``contractor'' means an entity 
        performing a covered contract.
            (5) Contract personnel.--The term ``contract personnel'' 
        means persons assigned by a contractor (including 
        subcontractors at any tier) to perform work under a covered 
        contract.

SEC. 5. EFFECTIVE DATE.

    (a) Applicability.--The provisions of this Act shall apply to all 
covered contracts and all covered contract personnel in which the work 
under the contract is carried out in an area, or in close proximity to 
an area (as designated by the Department of Defense), where the Armed 
Forces is conducting a contingency operation on or after the date of 
the enactment of this Act.
    (b) Immediate Effectiveness.--The provisions of this Act shall 
enter into effect immediately upon the enactment of this Act.
    (c) Implementation.--With respect to covered contracts and covered 
contract personnel discussed in subsection (a)(1), the Director of the 
Federal Bureau of Investigation, and the head of any other agency to 
which this Act applies, shall have 90 days after the date of the 
enactment of this Act to ensure compliance with the provisions of this 
Act.
[EX A]: Security Contractor Accountability Act of 2007 - Provides that persons who, while employed under a federal agency contract in or in close proximity to an area where the Armed Forces are conducting a contingency operation, engage in conduct that would constitute an offense punishable by imprisonment for more than one year if engaged in within U.S. jurisdiction shall be punished as provided for that offense.

Requires the Inspector General of the Department of Justice (DOJ) to report to Congress on the status of the Department's investigations of violations alleged to have been committed by contract personnel and findings and recommendations about the Department's capacity and effectiveness in prosecuting misconduct by contract personnel.

Requires the Director of the Federal Bureau of Investigation (FBI) to ensure, through the creation of Theater Investigative Units, that there are adequate personnel to investigate allegations of criminal violations by contract personnel.

[EX Q]: SECTION 1. COOPERATIVE EDUCATION.

    (a) Reservation for Continuation Awards.--The matter preceding 
paragraph (1) of section 802(b) of the Higher Education Act of 1965 (20 
U.S.C. 1133a(b)(1)) is amended to read as follows:
    ``(b) Reservations.--From the amounts appropriated pursuant to the 
authority of subsection (a) for fiscal year 1993 the Secretary shall 
reserve such sums as are necessary to make grant awards in accordance 
with section 803(a)(6) for such year. From the amounts appropriated 
pursuant to the authority of subsection (a) and not reserved pursuant 
to the preceding sentence in each fiscal year--''.
    (b) Clarification Regarding Subsequent Participation of Certain 
Grant Recipients.--Section 803 of the Higher Education Act of 1965 (20 
U.S.C. 1133b) is amended--
            (1) in subparagraph (A) of subsection (a)(1), by striking 
        ``that have not received a grant under this paragraph in the 
        10-year period preceding the date for which a grant under this 
        section is requested'';
            (2) in the heading of subsection (c), by inserting ``; 
        Subsequent Participation Rule'' after ``Share''; and
            (3) in subsection (c)--
                    (A) in the matter preceding subparagraph (A) of 
                paragraph (1), by striking ``No'' and inserting 
                ``Except as provided in paragraph (4), no'';
                    (B) in subparagraph (A), by inserting ``, except 
                that any grant awarded pursuant to section 802 of the 
                Higher Education Act of 1965 (as such Act was in effect 
                on July 22, 1992) shall be included in the calculation 
                of the 5 fiscal year period described in this 
                subparagraph'' before the semicolon; and
                    (C) by adding at the end the following new 
                paragraph:
            ``(4) Subsequent participation rule.--An institution of 
        higher education or a combination of such institutions shall be 
        eligible to receive a grant under subsection (a)(1)(A) after 
        the expiration of the 10 fiscal year period following the final 
        fiscal year in which such institution or combination receives 
        grant funds in accordance with subparagraph (A) or (B) of 
        paragraph (1).''.
    (c) Priority.--Subsection (a) of section 803 of the Higher 
Education Act of 1965 (20 U.S.C. 1135b) is further amended by adding at 
the end the following new paragraph:
            ``(6) Priority.--In awarding grants under paragraph (1)(A) 
        in any fiscal year the Secretary shall give priority to 
        institutions of higher education or combinations of such 
        institutions that have received grant funds in the preceding 
        fiscal year pursuant to a multiyear grant award under paragraph 
        (1)(A) or section 802 of the Higher Education Act of 1965 (as 
        such section was in effect on July 22, 1992).''.
    (d) Federal Share.--Subsection (c) of section 803 of the Higher 
Education Act of 1965 (20 U.S.C. 1133b(c)) is further amended--
            (1) in the matter preceding subparagraph (A) of paragraph 
        (2), by striking ``The'' and inserting ``Except as provided in 
        paragraph (3), the''; and
            (2) by amending paragraph (3) to read as follows:
            ``(3) Special rule.--The Secretary shall not waive the 
        provisions of this subsection, except that if an institution of 
        higher education or combination of such institutions received 
        grant funds under section 802 of the Higher Education Act of 
        1965 (as such section was in effect on July 22, 1992) pursuant 
        to a multiyear grant award and such institution or combination 
        is eligible to receive grant funds under this section, then the 
        Secretary shall waive the Federal share provisions set forth in 
        paragraph (2) for such institution or combination and shall 
        apply the Federal share provisions set forth in section 
        802(c)(2) of the Higher Education Act of 1965 (as such section 
        was in effect on July 22, 1992) to such institution or 
        combination for the duration of such multiyear grant award.''.
    (e) Availability of Appropriations.--Subsection (c) of section 802 
of the Higher Education Act of 1965 (20 U.S.C. 1133a(c)) is amended to 
read as follows:
    ``(c) Availability of Appropriations.--
            ``(1) Limitation regarding compensation of students.--
        Appropriations under this title shall not be available for the 
        payment of compensation of students for employment by employers 
        under arrangements pursuant to this title.
            ``(2) Special rule.--Funds appropriated pursuant to the 
        authority of subsection (a) for fiscal year 1993 shall remain 
        available for obligation until September 30, 1994.''.

SEC. 2. GRADUATE PROGRAMS.

    Notwithstanding any other provision of law, if an individual 
received multiyear fellowship assistance under part B, C, or D of title 
IX of the Higher Education Act of 1965 in fiscal year 1992, then the 
Secretary of Education shall apply the provisions of such parts (as 
such parts were in effect on July 22, 1992) for the remainder of the 
duration of such multiyear fellowship assistance.

SEC. 3. PACIFIC REGIONAL EDUCATIONAL LABORATORY.

    The matter preceding paragraph (1) of section 101A(b) of the Carl 
D. Perkins Vocational and Applied Technology Education Act (20 U.S.C. 
2311a(b)) is amended--
            (1) by striking ``Center for the Advancement of Pacific 
        Education, Honolulu, Hawaii, or its successor entity as the 
        Pacific regional educational laboratory'' and inserting 
        ``Pacific Regional Educational Laboratory, Honolulu, Hawaii''; 
        and
            (2) by inserting ``or provide direct services regarding'' 
        after ``grants for''.

SEC. 4. DISTRIBUTION OF FUNDS TO POSTSECONDARY AND ADULT PROGRAMS.

    Section 232 of the Carl D. Perkins Vocational and Applied 
Technology Education Act (20 U.S.C. 2341a) is amended--
            (1) in subsection (a)--
                    (A) in the first sentence, by inserting ``or 
                consortia thereof'' before ``within''; and
                    (B) in the second sentence--
                            (i) by inserting ``or consortium'' before 
                        ``shall''; and
                            (ii) by inserting ``or consortium'' before 
                        ``in the preceding'';
            (2) in subsection (b)--
                    (A) in paragraph (1), by inserting ``or consortia'' 
                after ``institutions''; and
                    (B) in the matter preceding subparagraph (A) of 
                paragraph (2), by inserting ``or consortia'' after 
                ``institutions''; and
            (3) in subsection (c)--
                    (A) in paragraph (1), by inserting ``or 
                consortium'' after ``institution''; and
                    (B) in paragraph (2), by inserting ``or consortia'' 
                after ``institutions''.

SEC. 5. NATIONAL BOARD FOR PROFESSIONAL TEACHING STANDARDS.

    Section 551 of the Higher Education Act of 1965 (20 U.S.C. 1107(f)) 
is amended--
            (1) in paragraph (1) of subsection (b), by striking ``the 
        Federal share of'';
            (2) in subparagraph (B) of subsection (e)(1), by striking 
        ``share of the cost of the activities of the Board is'' and 
        inserting ``contributions described in subsection (f) are''; 
        and
            (3) by amending subsection (f) to read as follows:
    ``(f) Matching Funds Requirement.--
            ``(1) In general.--The Secretary shall not provide 
        financial assistance under this subpart to the Board unless the 
        Board agrees to expend non-Federal contributions equal to $1 
        for every $1 of the Federal funds provided pursuant to such 
        financial assistance.
            ``(2) Non-federal contributions.--The non-Federal 
        contributions described in paragraph (1)--
                    ``(A) may include all non-Federal funds raised by 
                the Board on or after January 1, 1987; and
                    ``(B) may be used for outreach, implementation, 
                administration, operation, and other costs associated 
                with the development and implementation of national 
                teacher assessment and certification procedures under 
                this subpart.''.

            Passed the Senate May 4 (legislative day, April 19), 1993.

            Attest:

                                             WALTER J. STEWART,

                                                             Secretary.
[EX A]:
Amends the Higher Education Act of 1965 (HEA) to revise provisions for cooperative education grants to institutions and other entities with respect to:  (1) reservation of funds for certain grant awards; (2) subsequent participation of certain grantees; (3) priority in awarding grants; (4) Federal share; and (5) availability of appropriations. 
Directs the Secretary of Education to apply the provisions of specified graduate fellowship programs under HEA as they were in effect on July 22, 1992, for the remainder of such multiyear fellowship assistance for any individual who received such assistance in FY 1992. 
Revises HEA provisions for the National Board for Professional Teaching Standards with respect to a matching funds requirement. 
Amends the Carl D. Perkins Vocational and Applied Technology Education Act with respect to:  (1) the Pacific Regional Educational Laboratory; and (2) distribution of funds to postsecondary and adult programs.